AU Patent

AU2021224588B2 — Antiviral compounds

Assigned to Gilead Sciences Inc · Expires 2024-07-18 · 2y expired

What this patent protects

The present disclosure describes 4'-fluoromethyl nucleosides for treating viral infections, including Dengue.

USPTO Abstract

The present disclosure describes 4'-fluoromethyl nucleosides for treating viral infections, including Dengue.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021224588B2
Jurisdiction
AU
Classification
—
Expires
2024-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.